Lucien Maria Koymans

Title: **Lucien Maria Koymans: Innovator in HIV Treatment**

Introduction

Lucien Maria Koymans is an accomplished inventor based in Turnhout, Belgium, known for his significant contributions to the field of pharmaceutical science. With a focus on innovative compounds that target serious health issues, Koymans continues to play a crucial role in the ongoing fight against diseases like HIV.

Latest Patents

Koymans holds one notable patent, titled “Trisubstituted 1,3,5-Triazine Derivatives”. This invention encompasses a series of compounds designed for pharmaceutical applications in the treatment of subjects suffering from Human Immunodeficiency Virus (HIV) infection. The patent outlines specific chemical formulas and potential uses, including N-oxides, pharmaceutically acceptable addition salts, and various stereochemically isomeric forms of the compounds.

Career Highlights

Koymans is associated with Janssen Pharmaceutica NV, a prominent player in the pharmaceutical industry. His work there involves extensive research and development aimed at creating effective treatment options for HIV and possibly other health conditions.

Collaborations

Throughout his career, Lucien Maria Koymans has collaborated with notable colleagues, including Frederik Frans Daeyaert and Bart L De Corte. These partnerships highlight the importance of teamwork in innovative research and development within the pharmaceutical sector.

Conclusion

Lucien Maria Koymans exemplifies the spirit of innovation in the pharmaceutical industry. His patent reflects a commitment to addressing critical health challenges, particularly in the area of HIV treatment. With ongoing research and collaboration, Koymans continues to contribute valuable solutions that have the potential to impact lives significantly.